DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice (original) (raw)
Gattinoni L, Powell Jr DJ, Rosenberg SA, Restifo NP . Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 2006; 6: 383–393. ArticleCASPubMed CentralPubMed Google Scholar
Vieweg J, Su Z, Dahm P, Kusmartsev S . Reversal of tumor-mediated immunosuppression. Clin Cancer Res 2007; 13: 727s–732s. ArticleCASPubMed Google Scholar
Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW . Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat Biotechnol 1999; 17: 253–258. ArticleCASPubMed Google Scholar
Kim JJ, Trivedi NN, Wilson DM, Mahalingam S, Morrison L, Tsai A et al. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine (published erratum appears in Oncogene 1999 Apr 8;18(14):2411). Oncogene 1998; 17: 3125–3135. ArticleCASPubMed Google Scholar
Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A et al. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine 2007; 25: 3022–3031. ArticleCASPubMed Google Scholar
Monzavi-Karbassi B, Artaud C, Jousheghany F, Hennings L, Carcel-Trullols J, Shaaf S et al. Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. J Immunol 2005; 174: 7057–7065. ArticleCASPubMed Google Scholar
Petrovan RJ, Kaplan CD, Reisfeld RA, Curtiss LK . DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27: 1095–1100. ArticleCASPubMed Google Scholar
Kaplan CD, Kruger JA, Zhou H, Luo Y, Xiang R, Reisfeld RA . A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine 2006; 24: 6994–7002. ArticleCASPubMed Google Scholar
Scanlan MJ, Simpson AJ, Old LJ . The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004; 4: 1. PubMed Google Scholar
Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ . Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 615–625. ArticleCASPubMed Google Scholar
Zendman AJ, Ruiter DJ, Van Muijen GN . Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003; 194: 272–288. ArticleCASPubMed Google Scholar
Klenova EM, Morse III HC, Ohlsson R, Lobanenkov VV . The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol 2002; 12: 399–414. ArticleCASPubMed Google Scholar
Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 2002; 99: 6806–6811. ArticleCASPubMed CentralPubMed Google Scholar
Loukinov D, Ghochikyan A, Mkrtichyan M, Ichim TE, Lobanenkov VV, Cribbs DH et al. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant. J Cell Biochem 2006; 98: 1037–1043. ArticleCASPubMed Google Scholar
Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI et al. Conditional expression of the CTCF-Paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 2005; 65: 7751–7762. ArticleCASPubMed Google Scholar
Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR et al. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res 2005; 65: 7763–7774. ArticleCASPubMed Google Scholar
Ghochikyan A, Mkrtichyan M, Loukinov D, Mamikonyan G, Pack SD, Movsesyan N et al. Epigenetically acting tumor promoting transcription factor BORIS is widely expressed TAA inducing anti-tumor specific T cell responses. J Immunol 2007; 178: 556–573. Article Google Scholar
Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 2003; 171: 3823–3836. ArticleCASPubMed Google Scholar
Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM . M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166–6173. ArticleCASPubMed Google Scholar
Miller FR, Miller BE, Heppner GH . Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis 1983; 3: 22–31. CASPubMed Google Scholar
Aslakson CJ, Miller FR . Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52: 1399–1405. CASPubMed Google Scholar
Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P et al. A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 1999; 17: 163–170. ArticleCASPubMed Google Scholar
Pulaski BA, Ostrand-Rosenberg S . Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 1998; 58: 1486–1493. CASPubMed Google Scholar
Pulaski BA, Terman DS, Khan S, Muller E, Ostrand-Rosenberg S . Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res 2000; 60: 2710–2715. CASPubMed Google Scholar